Share Price and Basic Stock Data
Last Updated: May 31, 2025, 8:27 pm
PEG Ratio | 0.25 |
---|
Competitors of Vadilal Industries Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Modern Dairies Ltd | 141 Cr. | 54.8 | 76.0/41.5 | 5.20 | 15.8 | 0.00 % | % | % | 10.0 |
Healthy Life Agritec Ltd | 151 Cr. | 60.8 | 97.2/18.1 | 46.2 | 13.8 | 0.00 % | 13.2 % | 10.6 % | 10.0 |
Dodla Dairy Ltd | 7,420 Cr. | 1,230 | 1,371/820 | 28.6 | 233 | 0.24 % | 27.3 % | 20.4 % | 10.0 |
Vadilal Industries Ltd | 3,838 Cr. | 5,338 | 7,399/3,411 | 25.5 | 967 | 0.03 % | 25.4 % | 24.3 % | 10.0 |
Umang Dairies Ltd | 175 Cr. | 79.3 | 165/67.0 | 286 | 20.7 | 0.00 % | 4.52 % | 1.35 % | 5.00 |
Industry Average | 5,280.57 Cr | 1,161.70 | 69.44 | 204.67 | 0.22% | 18.47% | 15.98% | 7.29 |
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 213 | 391 | 267 | 143 | 256 | 411 | 289 | 174 | 251 | 464 | 296 | 204 | 274 |
Expenses | 173 | 316 | 223 | 149 | 208 | 307 | 230 | 163 | 206 | 351 | 235 | 178 | 236 |
Operating Profit | 40 | 75 | 44 | -6 | 49 | 104 | 59 | 11 | 46 | 113 | 61 | 26 | 39 |
OPM % | 19% | 19% | 17% | -4% | 19% | 25% | 20% | 6% | 18% | 24% | 20% | 13% | 14% |
Other Income | 2 | 4 | 4 | 4 | 2 | 2 | 4 | 4 | 3 | 4 | 5 | 4 | 3 |
Interest | 5 | 5 | 3 | 4 | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 3 | 4 |
Depreciation | 6 | 7 | 8 | 6 | 8 | 9 | 9 | 8 | 9 | 11 | 11 | 10 | 11 |
Profit before tax | 30 | 67 | 37 | -12 | 38 | 92 | 50 | 3 | 35 | 103 | 52 | 17 | 27 |
Tax % | 28% | 26% | 27% | -22% | 24% | 23% | 24% | -210% | 21% | 25% | 25% | 31% | 19% |
Net Profit | 22 | 49 | 27 | -9 | 29 | 71 | 38 | 9 | 28 | 77 | 39 | 12 | 22 |
EPS in Rs | 30.18 | 68.81 | 38.02 | -12.92 | 40.04 | 98.81 | 52.94 | 12.86 | 38.45 | 107.71 | 54.23 | 16.60 | 30.61 |
Last Updated: May 31, 2025, 7:23 am
Below is a detailed analysis of the quarterly data for Vadilal Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 274.00 Cr.. The value appears strong and on an upward trend. It has increased from 204.00 Cr. (Dec 2024) to 274.00 Cr., marking an increase of 70.00 Cr..
- For Expenses, as of Mar 2025, the value is 236.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 178.00 Cr. (Dec 2024) to 236.00 Cr., marking an increase of 58.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Dec 2024) to 39.00 Cr., marking an increase of 13.00 Cr..
- For OPM %, as of Mar 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Dec 2024) to 14.00%, marking an increase of 1.00%.
- For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Mar 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Dec 2024) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 10.00 Cr..
- For Tax %, as of Mar 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 31.00% (Dec 2024) to 19.00%, marking a decrease of 12.00%.
- For Net Profit, as of Mar 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Dec 2024) to 22.00 Cr., marking an increase of 10.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 30.61. The value appears strong and on an upward trend. It has increased from 16.60 (Dec 2024) to 30.61, marking an increase of 14.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 2:28 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 324 | 367 | 406 | 450 | 482 | 547 | 567 | 599 | 463 | 698 | 1,058 | 1,125 | 1,215 |
Expenses | 287 | 327 | 367 | 391 | 425 | 499 | 494 | 521 | 428 | 599 | 892 | 904 | 970 |
Operating Profit | 37 | 40 | 39 | 58 | 57 | 48 | 73 | 79 | 36 | 99 | 166 | 221 | 245 |
OPM % | 11% | 11% | 10% | 13% | 12% | 9% | 13% | 13% | 8% | 14% | 16% | 20% | 20% |
Other Income | 7 | 2 | 3 | 1 | 3 | 6 | 10 | 10 | 16 | 8 | 10 | 12 | 17 |
Interest | 25 | 25 | 26 | 21 | 16 | 15 | 14 | 17 | 21 | 19 | 16 | 18 | 14 |
Depreciation | 11 | 13 | 13 | 14 | 15 | 16 | 17 | 24 | 23 | 24 | 30 | 35 | 41 |
Profit before tax | 8 | 4 | 4 | 24 | 29 | 23 | 52 | 48 | 8 | 64 | 131 | 180 | 207 |
Tax % | 39% | 36% | 36% | 40% | 35% | 32% | 36% | 14% | 40% | 30% | 26% | 19% | |
Net Profit | 5 | 2 | 2 | 15 | 19 | 16 | 33 | 41 | 5 | 45 | 96 | 146 | 156 |
EPS in Rs | 7.00 | 3.20 | 3.39 | 20.53 | 26.52 | 21.79 | 46.41 | 57.57 | 6.44 | 62.19 | 133.96 | 203.05 | 216.99 |
Dividend Payout % | 21% | 31% | 29% | 6% | 5% | 6% | 3% | 0% | 0% | 2% | 1% | 1% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -60.00% | 0.00% | 650.00% | 26.67% | -15.79% | 106.25% | 24.24% | -87.80% | 800.00% | 113.33% | 52.08% |
Change in YoY Net Profit Growth (%) | 0.00% | 60.00% | 650.00% | -623.33% | -42.46% | 122.04% | -82.01% | -112.05% | 887.80% | -686.67% | -61.25% |
Vadilal Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 16% |
3 Years: | 21% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 55% |
5 Years: | 30% |
3 Years: | 50% |
TTM: | 3% |
Stock Price CAGR | |
---|---|
10 Years: | 26% |
5 Years: | 57% |
3 Years: | 40% |
1 Year: | 24% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 23% |
3 Years: | 27% |
Last Year: | 24% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 14, 2024, 2:30 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Reserves | 106 | 106 | 106 | 120 | 154 | 168 | 200 | 240 | 244 | 290 | 390 | 535 | 651 |
Borrowings | 172 | 166 | 152 | 122 | 119 | 141 | 148 | 174 | 158 | 186 | 291 | 223 | 155 |
Other Liabilities | 68 | 97 | 104 | 117 | 134 | 123 | 122 | 153 | 159 | 140 | 150 | 151 | 155 |
Total Liabilities | 353 | 376 | 370 | 366 | 414 | 439 | 477 | 574 | 567 | 623 | 838 | 917 | 967 |
Fixed Assets | 207 | 228 | 226 | 225 | 251 | 257 | 267 | 318 | 312 | 307 | 403 | 444 | 436 |
CWIP | 16 | 4 | 1 | 1 | 5 | 7 | 13 | 9 | 5 | 3 | 20 | 12 | 12 |
Investments | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 16 | 93 |
Other Assets | 129 | 144 | 143 | 141 | 158 | 175 | 196 | 247 | 250 | 313 | 410 | 445 | 426 |
Total Assets | 353 | 376 | 370 | 366 | 414 | 439 | 477 | 574 | 567 | 623 | 838 | 917 | 967 |
Below is a detailed analysis of the balance sheet data for Vadilal Industries Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
- For Reserves, as of Sep 2024, the value is 651.00 Cr.. The value appears strong and on an upward trend. It has increased from 535.00 Cr. (Mar 2024) to 651.00 Cr., marking an increase of 116.00 Cr..
- For Borrowings, as of Sep 2024, the value is 155.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 223.00 Cr. (Mar 2024) to 155.00 Cr., marking a decrease of 68.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is 155.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 151.00 Cr. (Mar 2024) to 155.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is 967.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 917.00 Cr. (Mar 2024) to 967.00 Cr., marking an increase of 50.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is 436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 444.00 Cr. (Mar 2024) to 436.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2024, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
- For Investments, as of Sep 2024, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 77.00 Cr..
- For Other Assets, as of Sep 2024, the value is 426.00 Cr.. The value appears to be declining and may need further review. It has decreased from 445.00 Cr. (Mar 2024) to 426.00 Cr., marking a decrease of 19.00 Cr..
- For Total Assets, as of Sep 2024, the value is 967.00 Cr.. The value appears strong and on an upward trend. It has increased from 917.00 Cr. (Mar 2024) to 967.00 Cr., marking an increase of 50.00 Cr..
Notably, the Reserves (651.00 Cr.) exceed the Borrowings (155.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -135.00 | -126.00 | -113.00 | -64.00 | -62.00 | -93.00 | -75.00 | -95.00 | -122.00 | -87.00 | -125.00 | -2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 14 | 15 | 14 | 18 | 8 | 28 | 20 | 27 | 36 | 34 | 27 | 31 |
Inventory Days | 176 | 178 | 144 | 138 | 135 | 119 | 157 | 179 | 211 | 170 | 167 | 146 |
Days Payable | 79 | 104 | 96 | 104 | 92 | 91 | 86 | 98 | 165 | 85 | 58 | 62 |
Cash Conversion Cycle | 111 | 89 | 62 | 51 | 51 | 56 | 91 | 107 | 81 | 119 | 135 | 115 |
Working Capital Days | 38 | 21 | 9 | 3 | 12 | 31 | 38 | 50 | 51 | 69 | 82 | 80 |
ROCE % | 12% | 10% | 10% | 18% | 17% | 13% | 20% | 17% | 7% | 19% | 26% | 27% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 203.05 | 133.97 | 62.19 | 6.44 | 57.57 |
Diluted EPS (Rs.) | 203.05 | 133.97 | 62.19 | 6.44 | 57.57 |
Cash EPS (Rs.) | 251.54 | 175.54 | 95.54 | 38.23 | 90.53 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 650.05 | 448.45 | 309.43 | 245.06 | 239.47 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 754.70 | 553.13 | 414.11 | 349.74 | 344.15 |
Revenue From Operations / Share (Rs.) | 1565.13 | 1471.74 | 970.70 | 645.25 | 833.73 |
PBDIT / Share (Rs.) | 323.74 | 245.27 | 149.13 | 72.31 | 122.91 |
PBIT / Share (Rs.) | 275.19 | 203.70 | 115.77 | 40.52 | 89.95 |
PBT / Share (Rs.) | 250.29 | 181.64 | 88.80 | 10.69 | 66.69 |
Net Profit / Share (Rs.) | 202.99 | 133.97 | 62.19 | 6.44 | 57.57 |
NP After MI And SOA / Share (Rs.) | 202.99 | 133.97 | 62.19 | 6.44 | 57.57 |
PBDIT Margin (%) | 20.68 | 16.66 | 15.36 | 11.20 | 14.74 |
PBIT Margin (%) | 17.58 | 13.84 | 11.92 | 6.27 | 10.78 |
PBT Margin (%) | 15.99 | 12.34 | 9.14 | 1.65 | 7.99 |
Net Profit Margin (%) | 12.96 | 9.10 | 6.40 | 0.99 | 6.90 |
NP After MI And SOA Margin (%) | 12.96 | 9.10 | 6.40 | 0.99 | 6.90 |
Return on Networth / Equity (%) | 31.24 | 29.90 | 20.12 | 2.63 | 24.08 |
Return on Capital Employeed (%) | 28.15 | 26.02 | 20.52 | 8.69 | 19.27 |
Return On Assets (%) | 15.91 | 11.49 | 7.17 | 0.81 | 7.21 |
Long Term Debt / Equity (X) | 0.08 | 0.18 | 0.34 | 0.32 | 0.28 |
Total Debt / Equity (X) | 0.25 | 0.63 | 0.77 | 0.72 | 0.90 |
Asset Turnover Ratio (%) | 1.28 | 1.45 | 1.01 | 0.66 | 1.02 |
Current Ratio (X) | 2.02 | 1.44 | 1.39 | 1.04 | 0.98 |
Quick Ratio (X) | 0.95 | 0.51 | 0.63 | 0.43 | 0.33 |
Inventory Turnover Ratio (X) | 2.05 | 2.51 | 2.33 | 1.52 | 2.13 |
Dividend Payout Ratio (NP) (%) | 0.73 | 0.93 | 0.00 | 0.00 | 2.61 |
Dividend Payout Ratio (CP) (%) | 0.59 | 0.71 | 0.00 | 0.00 | 1.66 |
Earning Retention Ratio (%) | 99.27 | 99.07 | 0.00 | 0.00 | 97.39 |
Cash Earning Retention Ratio (%) | 99.41 | 99.29 | 0.00 | 0.00 | 98.34 |
Interest Coverage Ratio (X) | 13.00 | 11.12 | 5.53 | 2.42 | 5.29 |
Interest Coverage Ratio (Post Tax) (X) | 9.15 | 7.07 | 3.31 | 1.22 | 3.48 |
Enterprise Value (Cr.) | 3189.08 | 1750.95 | 1137.24 | 737.41 | 460.85 |
EV / Net Operating Revenue (X) | 2.83 | 1.66 | 1.63 | 1.59 | 0.76 |
EV / EBITDA (X) | 13.70 | 9.93 | 10.61 | 14.19 | 5.22 |
MarketCap / Net Operating Revenue (X) | 2.78 | 1.50 | 1.46 | 1.39 | 0.54 |
Retention Ratios (%) | 99.26 | 99.06 | 0.00 | 0.00 | 97.38 |
Price / BV (X) | 6.69 | 4.92 | 4.58 | 3.67 | 1.89 |
Price / Net Operating Revenue (X) | 2.78 | 1.50 | 1.46 | 1.39 | 0.54 |
EarningsYield | 0.04 | 0.06 | 0.04 | 0.01 | 0.12 |
After reviewing the key financial ratios for Vadilal Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 203.05. This value is within the healthy range. It has increased from 133.97 (Mar 23) to 203.05, marking an increase of 69.08.
- For Diluted EPS (Rs.), as of Mar 24, the value is 203.05. This value is within the healthy range. It has increased from 133.97 (Mar 23) to 203.05, marking an increase of 69.08.
- For Cash EPS (Rs.), as of Mar 24, the value is 251.54. This value is within the healthy range. It has increased from 175.54 (Mar 23) to 251.54, marking an increase of 76.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 650.05. It has increased from 448.45 (Mar 23) to 650.05, marking an increase of 201.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 754.70. It has increased from 553.13 (Mar 23) to 754.70, marking an increase of 201.57.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,565.13. It has increased from 1,471.74 (Mar 23) to 1,565.13, marking an increase of 93.39.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 323.74. This value is within the healthy range. It has increased from 245.27 (Mar 23) to 323.74, marking an increase of 78.47.
- For PBIT / Share (Rs.), as of Mar 24, the value is 275.19. This value is within the healthy range. It has increased from 203.70 (Mar 23) to 275.19, marking an increase of 71.49.
- For PBT / Share (Rs.), as of Mar 24, the value is 250.29. This value is within the healthy range. It has increased from 181.64 (Mar 23) to 250.29, marking an increase of 68.65.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 202.99. This value is within the healthy range. It has increased from 133.97 (Mar 23) to 202.99, marking an increase of 69.02.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 202.99. This value is within the healthy range. It has increased from 133.97 (Mar 23) to 202.99, marking an increase of 69.02.
- For PBDIT Margin (%), as of Mar 24, the value is 20.68. This value is within the healthy range. It has increased from 16.66 (Mar 23) to 20.68, marking an increase of 4.02.
- For PBIT Margin (%), as of Mar 24, the value is 17.58. This value is within the healthy range. It has increased from 13.84 (Mar 23) to 17.58, marking an increase of 3.74.
- For PBT Margin (%), as of Mar 24, the value is 15.99. This value is within the healthy range. It has increased from 12.34 (Mar 23) to 15.99, marking an increase of 3.65.
- For Net Profit Margin (%), as of Mar 24, the value is 12.96. This value exceeds the healthy maximum of 10. It has increased from 9.10 (Mar 23) to 12.96, marking an increase of 3.86.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.96. This value is within the healthy range. It has increased from 9.10 (Mar 23) to 12.96, marking an increase of 3.86.
- For Return on Networth / Equity (%), as of Mar 24, the value is 31.24. This value is within the healthy range. It has increased from 29.90 (Mar 23) to 31.24, marking an increase of 1.34.
- For Return on Capital Employeed (%), as of Mar 24, the value is 28.15. This value is within the healthy range. It has increased from 26.02 (Mar 23) to 28.15, marking an increase of 2.13.
- For Return On Assets (%), as of Mar 24, the value is 15.91. This value is within the healthy range. It has increased from 11.49 (Mar 23) to 15.91, marking an increase of 4.42.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.18 (Mar 23) to 0.08, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.25. This value is within the healthy range. It has decreased from 0.63 (Mar 23) to 0.25, marking a decrease of 0.38.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.28. It has decreased from 1.45 (Mar 23) to 1.28, marking a decrease of 0.17.
- For Current Ratio (X), as of Mar 24, the value is 2.02. This value is within the healthy range. It has increased from 1.44 (Mar 23) to 2.02, marking an increase of 0.58.
- For Quick Ratio (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 23) to 0.95, marking an increase of 0.44.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.05. This value is below the healthy minimum of 4. It has decreased from 2.51 (Mar 23) to 2.05, marking a decrease of 0.46.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 20. It has decreased from 0.93 (Mar 23) to 0.73, marking a decrease of 0.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.59. This value is below the healthy minimum of 20. It has decreased from 0.71 (Mar 23) to 0.59, marking a decrease of 0.12.
- For Earning Retention Ratio (%), as of Mar 24, the value is 99.27. This value exceeds the healthy maximum of 70. It has increased from 99.07 (Mar 23) to 99.27, marking an increase of 0.20.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 99.41. This value exceeds the healthy maximum of 70. It has increased from 99.29 (Mar 23) to 99.41, marking an increase of 0.12.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 13.00. This value is within the healthy range. It has increased from 11.12 (Mar 23) to 13.00, marking an increase of 1.88.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.15. This value is within the healthy range. It has increased from 7.07 (Mar 23) to 9.15, marking an increase of 2.08.
- For Enterprise Value (Cr.), as of Mar 24, the value is 3,189.08. It has increased from 1,750.95 (Mar 23) to 3,189.08, marking an increase of 1,438.13.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.83. This value is within the healthy range. It has increased from 1.66 (Mar 23) to 2.83, marking an increase of 1.17.
- For EV / EBITDA (X), as of Mar 24, the value is 13.70. This value is within the healthy range. It has increased from 9.93 (Mar 23) to 13.70, marking an increase of 3.77.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.78. This value is within the healthy range. It has increased from 1.50 (Mar 23) to 2.78, marking an increase of 1.28.
- For Retention Ratios (%), as of Mar 24, the value is 99.26. This value exceeds the healthy maximum of 70. It has increased from 99.06 (Mar 23) to 99.26, marking an increase of 0.20.
- For Price / BV (X), as of Mar 24, the value is 6.69. This value exceeds the healthy maximum of 3. It has increased from 4.92 (Mar 23) to 6.69, marking an increase of 1.77.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.78. This value is within the healthy range. It has increased from 1.50 (Mar 23) to 2.78, marking an increase of 1.28.
- For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to 0.04, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vadilal Industries Ltd:
- Net Profit Margin: 12.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.15% (Industry Average ROCE: 18.47%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 31.24% (Industry Average ROE: 15.98%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.15
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.5 (Industry average Stock P/E: 69.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.96%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Milk & Milk Products | Vadilal House, Shrimali Society, Nr. Navrangpura Rly. Crossing, Ahmedabad Gujarat 380009 | shareslogs@vadilalgroup.com http://www.vadilalgroup.com |
Management | |
---|---|
Name | Position Held |
Mr. Preet Shah | Chairman & Ind.Director |
Mr. Devanshu L Gandhi | Managing Director |
Mr. Rajesh R Gandhi | Managing Director |
Mr. Kalpit R Gandhi | Non Exe.Non Ind.Director |
Mrs. Deval D Gandhi | Non Exe.Non Ind.Director |
Ms. Shaily Dedhia | Independent Director |
FAQ
What is the intrinsic value of Vadilal Industries Ltd?
Vadilal Industries Ltd's intrinsic value (as of 31 May 2025) is ₹4795.05 — 10.17% lower the current market price of 5,338.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,838 Cr. market cap, FY2025-2026 high/low of ₹7,399/3,411, reserves of 651 Cr, and liabilities of 967 Cr.
What is the Market Cap of Vadilal Industries Ltd?
The Market Cap of Vadilal Industries Ltd is 3,838 Cr..
What is the current Stock Price of Vadilal Industries Ltd as on 31 May 2025?
The current stock price of Vadilal Industries Ltd as on 31 May 2025 is 5,338.
What is the High / Low of Vadilal Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vadilal Industries Ltd stocks is ₹7,399/3,411.
What is the Stock P/E of Vadilal Industries Ltd?
The Stock P/E of Vadilal Industries Ltd is 25.5.
What is the Book Value of Vadilal Industries Ltd?
The Book Value of Vadilal Industries Ltd is 967.
What is the Dividend Yield of Vadilal Industries Ltd?
The Dividend Yield of Vadilal Industries Ltd is 0.03 %.
What is the ROCE of Vadilal Industries Ltd?
The ROCE of Vadilal Industries Ltd is 25.4 %.
What is the ROE of Vadilal Industries Ltd?
The ROE of Vadilal Industries Ltd is 24.3 %.
What is the Face Value of Vadilal Industries Ltd?
The Face Value of Vadilal Industries Ltd is 10.0.